- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02218112
Impact of Weight Loss After a Bypass Surgery on Renal Hemodynamic Under Stress Conditions (OBBYSS)
Effect of Weight Loss Induced by a Bypass Surgery on Renal Salt Excretion, Renal Hemodynamic and on Neurohormonal Responses During an Induced Orthostatic Stress in Obese Patients
The sympathetic nervous (SNS) and the renin angiotensin aldosterone system (RAS) have a direct impact on renal hemodynamic, hormonal secretion and vasoactive peptide. Many mechanisms including the SNS, RAS and renal sodium handling could explain the pathogenesis of hypertension in obese patients. Lifestyle changes and bariatric surgery induce weight loss, which is associated with blood pressure lowering in obese patients. A diminution in the renal sympathetic stimulation and RAS activation could explain this effect.
The AIM of this study is to show that weight loss induced by bypass surgery in obese patients affects renal salt excretion under " low body negative pressure (LBNP)" conditions .
Secondary objectives are to investigate the impact of weight loss on renal hemodynamic (glomerular filtration rate (GFR), renal plasma flow) and neurohormonal responses under " low body negative pressure conditions ". We will also analyse renal blood oxygenation with Blood Oxygenation dependant IRM (BOLD-IRM) technique before and after weight loss.
The population of this study will consist in two groups including 36 patients. The first one will include 24 obese patients that are going to undergo a bariatric surgery. The second one will include 12 obese patients without any weight loss associated surgery.
Both group will undergo 3 investigation days. Each patient will have to undergo a screening visit that will provide dietary advice to ensure a standardized salt intake (120-180 mmol/day) for the duration of the study. The first investigation will define baseline, the second and third day of investigation will take place after 3 month and 12 month after bariatric surgery for surgical patients or after baseline for patients without surgery. One to two weeks before phase 1 and 3 patients will perform a BOLD-MRI. The surgery group will undergo bariatric surgery between the first investigation phase (baseline) and the second. An ambulatory blood pressure and 24-hour urine collection will precede each investigation day. An investigation day consists in renal hemodynamics, neurohormonal and natriuretic response measurements before, during and after 60 min of LBNP at -30mbar . The duration of the study per subject is going to take 12 months.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1004
- Centre Hospitalier Universitaire Vaudois
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- BMI >35 Kg/m2
- Understanding and signing the informed consent
- Estimated glomerular filtration rate >60 ml/min/1.73 m2
Exclusion Criteria:
- Acute disease
- Asthma or history of asthma
- Patient participating in another clinical trial 30 days before the beginning of the study
- Blood donation (450ml) 2 months before the beginning of the study
- Chronic medication which influence renal function (NSAIDS, Others)
- Allergy
- Documented renal arterial stenosis
- History of symptomatic orthostatic hypotension
- Kidney transplantation
- Kidney malformation / polycystic kidney disease
- Impaired judgement
- Liver failure with ascitis
- Hip circumference at the upper anterior iliac spine > 130cm
- Waist circumference >180cm and weighing > 220kg
- Contraindication/Allergy to furosemide, PAH or Inulin
- Contraindication to MRI if the patient is going to undergo BOLD-MRI
- Postprandial glycemia > 11.0 mmol/L in diabetic patients
- Blood pressure > 180/110 assessed by 24 hour blood pressure measurement
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
OB - Bariatric surgery (gastric bypass)
Obese patients who will undergo a bariatric surgery (gastric bypass)
|
|
|
OB- Control group
Obese patients who will not undergo surgery - Control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in sodium excretion
Time Frame: up to one year
|
Change in sodium excretion during LBNP conditions
|
up to one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure, renal hemodynamic and neurohormonal response
Time Frame: up to one year
|
|
up to one year
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SNF_ 32003B_149903
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on bariatric surgery (gastric bypass)
-
University of Southern DenmarkCompletedObstructive Sleep Apnoea (OSA)Denmark
-
Unidad Internacional de Cirugia Bariatrica y MetabolicaRecruitingGERD | Bariatric Surgery Candidate | Revisional Bariatric SurgeryVenezuela
-
Federal University of São PauloCompleted
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknownInflammation | Obesity | Metabolic Syndrome | Morbid Obesity | Energy BalanceBrazil
-
Ali AminianNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The...CompletedObesity | Type 2 Diabetes MellitusUnited States
-
University of AarhusCompletedComplications After Bariatric SurgeryDenmark
-
Hospital General TlahuacCompletedObesity, Morbid | Complication of Surgical Procedure | Bariatric SurgeryMexico
-
Hospices Civils de LyonRecruitingSleeve Gastrectomy | Gastric Bypass Surgery | Metabolic Dysfunction-Associated Steatohepatitis | Metabolic Dysfunction-Associated Steatotic Liver DiseaseFrance
-
Hospices Civils de LyonCompleted
-
IRCCS Azienda Ospedaliera Universitaria San Martino...Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Azienda Ospedaliera... and other collaboratorsUnknown